152 related articles for article (PubMed ID: 1684553)
1. The potent vasodilating and guanylyl cyclase activating dinitrosyl-iron(II) complex is stored in a protein-bound form in vascular tissue and is released by thiols.
Mülsch A; Mordvintcev P; Vanin AF; Busse R
FEBS Lett; 1991 Dec; 294(3):252-6. PubMed ID: 1684553
[TBL] [Abstract][Full Text] [Related]
2. Specificity of different organic nitrates to elicit NO formation in rabbit vascular tissues and organs in vivo.
Mülsch A; Bara A; Mordvintcev P; Vanin A; Busse R
Br J Pharmacol; 1995 Nov; 116(6):2743-9. PubMed ID: 8590999
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of glutathione reductase by dinitrosyl-iron-dithiolate complex.
Boese M; Keese MA; Becker K; Busse R; Mülsch A
J Biol Chem; 1997 Aug; 272(35):21767-73. PubMed ID: 9268306
[TBL] [Abstract][Full Text] [Related]
4. Evidence for N-acetylcysteine-sensitive nitric oxide storage as dinitrosyl-iron complexes in lipopolysaccharide-treated rat aorta.
Muller B; Kleschyov AL; Stoclet JC
Br J Pharmacol; 1996 Nov; 119(6):1281-5. PubMed ID: 8937735
[TBL] [Abstract][Full Text] [Related]
5. L-cysteine-mediated destabilization of dinitrosyl iron complexes in proteins.
Rogers PA; Ding H
J Biol Chem; 2001 Aug; 276(33):30980-6. PubMed ID: 11423535
[TBL] [Abstract][Full Text] [Related]
6. Enzymic and nonenzymic release of NO accounts for the vasodilator activity of the metabolites of CAS 936, a novel long-acting sydnonimine derivative.
Mülsch A; Hecker M; Mordvintcev PI; Vanin AF; Busse R
Naunyn Schmiedebergs Arch Pharmacol; 1993 Jan; 347(1):92-100. PubMed ID: 8383302
[TBL] [Abstract][Full Text] [Related]
7. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
8. [Stability of a dinitrosyl iron complex with cysteine as a candidate for the role of blood vessel endothelial relaxation factor].
Vanin AF
Biokhimiia; 1995 Feb; 60(2):308-14. PubMed ID: 7718671
[TBL] [Abstract][Full Text] [Related]
9. The effects of nitroxyl (HNO) on soluble guanylate cyclase activity: interactions at ferrous heme and cysteine thiols.
Miller TW; Cherney MM; Lee AJ; Francoleon NE; Farmer PJ; King SB; Hobbs AJ; Miranda KM; Burstyn JN; Fukuto JM
J Biol Chem; 2009 Aug; 284(33):21788-21796. PubMed ID: 19531488
[TBL] [Abstract][Full Text] [Related]
10. Nitrogen monoxide transport mechanisms.
Mülsch A
Arzneimittelforschung; 1994 Mar; 44(3A):408-11. PubMed ID: 8185714
[TBL] [Abstract][Full Text] [Related]
11. [Formation of a new type of dinitrosyl iron complexes bound to cysteine modified with methylglyoxal].
Shumaev KB; Gubkina SA; Vanin AF; Burbaev DSh; Mokh VP; Topunov AF; Ruuge EK
Biofizika; 2013; 58(2):239-45. PubMed ID: 23755548
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms underlying relaxation of rabbit aorta by BAY 41-2272, a nitric oxide-independent soluble guanylate cyclase activator.
Priviero FB; Baracat JS; Teixeira CE; Claudino MA; De Nucci G; Antunes E
Clin Exp Pharmacol Physiol; 2005 Sep; 32(9):728-34. PubMed ID: 16173929
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of arterial contraction by dinitrosyl-iron complexes: critical role of the thiol ligand in determining rate of nitric oxide (NO) release and formation of releasable NO stores by S-nitrosation.
Alencar JL; Chalupsky K; Sarr M; Schini-Kerth V; Vanin AF; Stoclet JC; Muller B
Biochem Pharmacol; 2003 Dec; 66(12):2365-74. PubMed ID: 14637194
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of interaction between the sulfhydryl precursor L-methionine and glyceryl trinitrate.
Münzel T; Mülsch A; Holtz J; Just H; Harrison DG; Bassenge E
Circulation; 1992 Sep; 86(3):995-1003. PubMed ID: 1355413
[TBL] [Abstract][Full Text] [Related]
15. Low molecular mass dinitrosyl nonheme-iron complexes up-regulate noradrenaline release in the rat tail artery.
Kleschyov AL; Hubert G; Munzel T; Stoclet JC; Bucher B
BMC Pharmacol; 2002; 2():3. PubMed ID: 11872148
[TBL] [Abstract][Full Text] [Related]
16. [Dimeric and monomeric forms of dinitrosyl iron complexes with thiol-containing ligands: physico-chemical properties and vasodilator activity].
Vanin AF; Stukan RA; Manukhina EB
Biofizika; 1997; 42(1):10-21. PubMed ID: 9181782
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological mechanisms involved in the vasodilator effects of extracts from Echinodorus grandiflorus.
Tibiriçá E; Almeida A; Caillleaux S; Pimenta D; Kaplan MA; Lessa MA; Figueiredo MR
J Ethnopharmacol; 2007 Apr; 111(1):50-5. PubMed ID: 17150321
[TBL] [Abstract][Full Text] [Related]
18. Polynuclear water-soluble dinitrosyl iron complexes with cysteine or glutathione ligands: electron paramagnetic resonance and optical studies.
Vanin AF; Poltorakov AP; Mikoyan VD; Kubrina LN; Burbaev DS
Nitric Oxide; 2010 Sep; 23(2):136-49. PubMed ID: 20553936
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
Jia L; Furchgott RF
J Pharmacol Exp Ther; 1993 Oct; 267(1):371-8. PubMed ID: 8229764
[TBL] [Abstract][Full Text] [Related]
20. On the nature of a compound formed from dinitrosyl-iron complexes with cysteine and responsible for a long-lasting vasorelaxation.
Mokh VP; Poltorakov AP; Serezhenkov VA; Vanin AF
Nitric Oxide; 2010 May; 22(4):266-74. PubMed ID: 20067839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
